We report the construction of a series of Escherichia-Pseudomonas broad-host-range expression vectors utilizing the P BAD promoter and the araC regulator for routine cloning, conditional expression, and analysis of tightly controlled and/or toxic genes in pseudomonads.Gene cloning, disruption, deletion, complementation analysis, and allelic exchange are central to prokaryotic molecular genetics. In Pseudomonas aeruginosa, Schweizer and colleagues developed the pUCP family of general-purpose vectors for cloning and gene expression (24, 29) based on the well-characterized pUC18/19 vectors (32) and the cryptic mini-plasmid pRO1614 (19). Other promoters are also in routine use, such as the tac (4, 6), T7 (28), and araBAD promoter-based (8, 11) vectors for regulated expression in Escherichia coli and many other bacterial species (e.g., see references 2, 18, and 25). In E. coli, AraC represses the araBAD promoter (P BAD ) and the expression of a cloned gene is induced by the addition of L-arabinose. Pseudomonas researchers have used the inducible properties of the araC regulator and the P BAD promoter cassette for the controlled gene expression by integrating the araC-P BAD -specific transcription fusion into the chromosome by using a suicide vector or an integration-proficient vector (1,3,13,17,30,31). In the present study, we modified the existing EscherichiaPseudomonas shuttle vectors pUCP20T, -26, -28T, and -30T by replacing the lac promoter with the araC-P BAD cassette to allow conditional expression in pseudomonads and other bacteria, e.g., Burkholderia spp.Construction and features of pHERD vectors. Functional genetic analysis requires vectors capable of conditional expression. The P BAD promoter has been used for gene expression extensively in E. coli and some in P. aeruginosa and Burkholderia spp. (12,27,31). We first constructed three shuttle vectors, pHERD20T, -28T, and -30T (Fig. 1), based on EscherichiaPseudomonas shuttle vectors pUCP20T, pUCP28T, and pUCP30T (29) and the commercial expression vector pBAD/ Thio-TOPO (Invitrogen). The 368-bp fragment of the pUCP vectors spanning two restriction sites, AflII and EcoRI, was replaced with the araC-P BAD fragment (1.3 kb), produced via PCR with pBAD/Thio-TOPO as the template and primers pBAD-F and pBAD-R (Table 1). The PCR product was purified and directly digested with AflII and EcoRI, and the two fragments were ligated into the pUCP vectors, creating pHERD20T (Fig. 1). The EcoRI/AflII regions of these vectors were sequenced to confirm that no mutations were introduced during the cloning pro-